NCT04940299 2026-03-06Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial CarcinomaM.D. Anderson Cancer CenterPhase 2 Active not recruiting35 enrolled